Insight Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Insight Advisors's AMGN Position: Q1 2026 in Review
Insight Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,880 shares worth $661K. The position accounts for 0.13% of the portfolio, ranked #109.
Insight Advisors first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $703K in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Insight Advisors held 1,880 shares of Amgen worth $661K as of Q1 2026.
- Insight Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
- Amgen made up 0.13% of Insight Advisors's portfolio in Q1 2026, its #109 holding.
- Insight Advisors first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
- Insight Advisors's Amgen position peaked at $703K in Q4 2022.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.